State Stem Cell Agency Facilities Working Group Agenda 10-28-05

Return to CIRM Meetings and Events

 

 

 

 

 

 

 

 

 

California State Stem Cell Agency

Regular Meeting 10-28-05

SCIENTIFIC AND MEDICAL RESEARCH FACILITIES WORKING GROUP
(FACILITIES WORKING GROUP)
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT
 

Open Session

  1. Call to Order.
  2. Roll call.
  3. Pledge of Allegiance.
  4. Welcome and Introductions.

    [Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]

  5. President’s Report
    1. CIRM mandate, purpose and function.
    2. Functions of the Facilities Working Group (Health & Safety Code section 125290.65.)
  6. ICOC Update.
  7. Informational overview of CIRM grants: Facilities Working Group and Shared Space RFA.
  8. Consideration of review procedures for facilities grants.
  9. Consideration of bylaws for the Facilities Working Group.
  10. Consideration of future meetings.
  11. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.
  12. Adjournment.

 

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

 

 

**NOTICE**

 

The California Institute for Regenerative Medicine and its Independent Citizen’s Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at (415) 396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Scientific and Medical Research Funding Working Group meeting may be referred to Pat Beaupre Becker at the California Institute for Regenerative Medicine at pbecker@cirm.ca.gov or (415) 396-9105.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.

 

Transcripts

Date Published: April 7, 2009
Last Modified: April 5, 2017